| domain | oaktreeacquisitioncorp.com |
| summary | Oaktree Acquisition Corp. III Life Sciences is a SPAC focused on the life sciences sector. It recently completed a $175 million initial public offering (IPO) priced on October 23, 2024, and is preparing for the separate trading of its Class A ordinary shares and warrants, commencing December 16, 2024. This follows a shareholder approval of a business combination with Alvotech, a global biosimilars company, announced on June 6, 2022, with Alvotech set to debut on the Nasdaq under the ticker ALVO on June 16, 2022. |
| title | Home |
| description | Home |
| keywords | acquisition, contact, corp, news, life, sciences, vehicles, class, platform, best, broad, investing, capabilities, necessary, transaction, separate, trading |
| upstreams |
|
| downstreams |
|
| nslookup | A 104.16.213.134 |
| created | 2024-02-24 |
| updated | 2026-01-29 |
| summarized | 2026-01-31 |
|
|